Volume : 10, Issue : 07, July – 2023

Title:

33.REVIEW OF SOLID LIPID NANOPARTICLES BASED NANOGEL FOR DERMAL DELIVERY OF INDOMETHACIN

Authors :

Mr. Tushar Dilip Morankar, Dr. Kiran D. Baviskar

Nanogels composed of Nano size particles formed by physically or chemically cross linked polymer networks that swells in a good solvent. The nanogel systems have proven their potential to deliver drugs in controlled, constant and targetable mode. With the promising field of polymer sciences it has now become predestinated to prepare smart nano-system which can establish effectual for treatment, diagnosing as well as clinical trials progress.Nanogels is been proving as a promising drug delivery system and offers variety of characteristics like on site drug delivery system, sustained release formulation, high drug entrapment properties, water solubility, biodegradability, low toxicity etc. Due to these multi functionality properties and features nanogel utilized extensively in many drug deliver fields. Composite with polymers, metals and other active molecules nanogel turned out as excellent drug delivery system.Although, Indomethacin possesses some favorable properties for topical administration like low molecular weight, low daily therapeutic dose yet, the inherent poor aqueous solubility and high melting point make it unsuitable for topical application. It does not exhibit enough lipophilicity for permeation across the skin. A number of topical/transdermal drug delivery systems, which vary in their compositions and structures have been developed to improve the skin permeation of Indomethacin. However, the poor drug loading capacity, poor drug controlled and sustained release capacities have limited their use as topical/transdermal carriers. The level of interest in lipid-based carrier systems have increased substantially for topical administration of drugs because of the use of fats and oils of natural origin and pharmaceutically accepted surfactant as excipients.
Keywords: Solid Lipid Nanoparticles, Nanogel, Freeze drying.

Cite This Article:

Please cite this article in press Tushar Dilip Morankar et al, Review Of Solid Lipid Nanoparticles Based Nanogel For Dermal Delivery Of Indomethacin, Indo Am. J. P. Sci, 2023; 10 (07).

Number of Downloads : 10

References:

1. Chintala P. K., Padmapreetha J. Formulation and in-vitro evaluation of gel containing ethosomes entrapped with etodolac. International Journal of Pharmaceutical Science and Research. 2014;5(2):630–635.
2. Inoue N., Nogawa M., Ito S., Tajima K., Kume S., Kyoi T. The enantiomers of etodolac, a racemic anti-inflammatory agent, play different roles in efficacy and gastrointestinal safety. Biological and Pharmaceutical Bulletin. 2011;34(5):655–659. doi: 10.1248/bpb.34.655.
3. Kumar SS., Masilamani K., Srinivas SS., Ravichandiran V. Formulation and Physico-Chemical Evaluation of Ethylcellulose Microspheres Containing Etodolac. International Conference on Biotechnology and Pharmaceutical Sciences; 2011; pp. 372–375.
4. Barakat N. S. In vitro and in vivo characteristics of a thermogelling rectal delivery system of etodolac. APPS Pharmaceutical Science and Technology. 2009;10(3):724–731. doi: 10.1208/s12249-009-9261-y.
5. Tas C., Ozkan Y., Okyar A., Savaser A. In vitro and ex vivo permeation studies of etodolac from hydrophilic gels and effect of terpenes as enhancers. Drug Delivery. 2007;14(7):453–459. doi: 10.1080/10717540701603746.
6. Sharma N., Agarwal G., Rana A. C., Bhat Z. A., Kumar D. A review: transdermal drug delivery system: a tool for novel drug delivery system. International Journal of Drug Development and Research. 2011;3(3):70–84.
7. Bhowmik D., Chiranjib Chandira M., Jayakar B., Sampath K. P. Recent advances in transdermal drug delivery system. International Journal of Pharmaceutical Technology. 2010;2(1):68–77.
8. Balakrishnan P., Shanmugam S., Lee W. S., et al. Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery. International Journal of Pharmaceutics. 2009;377(1-2):1–8. doi: 10.1016/j.ijpharm.2009.04.020.
9. Firthouse P. U. M., Halith S. M., Wahab S. U., Sirajudeen M., Mohideen S. K. Formulation and evaluation of miconazole niosomes. International Journal of PharmTech Research. 2011;3(2):1019–1022.
10. Sathali A. A. H., Sangeetha T. Formulation and evaluation of ocular niosomal in situ gel of levofloxacin hemihydrates. Journal of Pharmacy Research. 2011;4:4331–4337.
11. Sathali A. A. H., Rajalakshmi G. Evaluation of transdermal targeted niosomal drug delivery of terbinafine hydrochloride. International Journal of PharmTech Research. 2010;2(3):2081–2089.
12. Solanki A. B., Parikh J. R., Parikh R. H., Patel M. R. Evaluation of different compositions of niosomes to optimize aceclofenac transdermal delivery. Asian Journal of Pharmaceutical Sciences. 2010;5(3):87–95.
13. Jain A., Deveda P., Vyas N. Development of antifungal emulsion based gel for topical fungal infections. International Journal of Pharmaceutical Research and Development. 2011;2:18–25.
14. Srikanth K., Nappinnai M., Gupta V. R. M., Suribabu J. Niosomes: a prominent tool for transdermal drug delivery. Research Journal of Pharmaceutical, Biological and Chemical Sciences. 2010;1(2):308–316.
15. Arora S., Prashar B., Dhamija H., Chandel A., Thakur V. Niosomes: the unique vesicular drug carriers. Journal of Drug Delivery & Therapeutics. 2012;2(1):96–101.
16. Shinde U. A., Kanojiya S. S. Serratiopeptidase niosomal gel with potential in topical delivery. Journal of Pharmaceutics. 2014;2014:9. doi: 10.1155/2014/382959.382959
17. Salih O. S., Samein L. H., Ali W. K. Formulation and in vitro evaluation of rosuvastatin calcium niosomes. International Journal of Pharmacy and Pharmaceutical Sciences. 2013;5(4):525–535.
18. Shilpa D. J., Vijay K. P. Formulation, development and evaluation of niosomal drug delivery system for clindamycin phosphate. Pharma Science Monitor. 2014;5(2):256–274.
19. Hadgraft J. Passive enhancement strategies in topical and transdermal drug delivery. International journal of pharmaceutics. 1999 Jul 5;184(1):1-6.
20. Kreilgaard M. Influence of microemulsions on cutaneous drug delivery. Advanced drug delivery reviews. 2002 Nov 1;54:S77-98.
21. Singh SK, Durrani MJ, Reddy IK, Khan MA. Effect of permeation enhancers on the release of ketoprofen through transdermal drug delivery systems. Die Pharmazie. 1996 Oct 1;51(10):741-4.
22. Ramesh P. Transdermal delivery of drugs. Indian journal of pharmacology. 1997 May 1;29(3):140.
23. Sinha VR, Kaur MP. Permeation enhancers for transdermal drug delivery. Drug development and industrial pharmacy. 2000 Jan 1;26(11):1131-40.
24. Gerard J. Tortora., Brayan Derrickson., Principles Of Anatomy and Physiology. Mithal BM, Saha RN. A handbook of cosmetics. Vallabh Prakashan, New Delhi. 2000;141.
25. Jain NK. Controlled and novel drug delivery CBS publishers & distributors. Daria Gang, New Delhi. 1997:101-27.
26. http://www.frost.com/prod/servlet/market-insight-print.pag?docid=134287829 [Accessed: Feb. 7, 2022].
27. https://www.boomer.org/c/p4/c07/c07.pdf [Accessed: Feb. 7, 2022].
28. https://www.marketsandmarkets.com/market-Reports/topical-drug-deliverymarket- 124871717.html [Accessed: Feb. 7, 2022].
29. Müller RH, Runge SA, Ravelli V, Thünemann AF, Mehnert W, Souto EB. Cyclosporine-loaded solid lipid nanoparticles (SLN®): Drug–lipid physicochemical interactions and characterization of drug incorporation. European journal of pharmaceutics and biopharmaceutics. 2008 Mar 1;68(3):535-44.
30. Lippacher A, Müller RH, Mäder K. Preparation of semisolid drug carriers for topical application based on solid lipid nanoparticles. International journal of pharmaceutics. 2001 Feb 19;214(1-2):9-12.
31. Pandya JB, Parmar RD, Soniwala MM, Chavda JR. Solid lipid nanoparticles: overview on excipients. Asian Journal of Pharmaceutical Technology & Innovation. 2013;1(3):01-9.
32. Mukherjee S, Ray S, Thakur RS. Solid lipid nanoparticles: a modern formulation approach in drug delivery system. Indian journal of pharmaceutical sciences. 2009 Jul;71(4):349.
33. Müller RH, Mäder K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery–a review of the state of the art. European journal of pharmaceutics and biopharmaceutics. 2000 Jul 3;50(1):161-77.
34. Kaur IP, Bhandari R, Bhandari S, Kakkar V. Potential of solid lipid nanoparticles in brain targeting. Journal of Controlled release. 2008 Apr 21;127(2):97-109

</div8